Acquiring Company
Profusa
Acquired Company
Privately held diagnostics and toxicology testing company
CaliforniaHealth CareMedicalBiotechnologyDescription
Profusa Inc. announced a non-binding term sheet to acquire a privately held diagnostics and toxicology testing company. This acquisition aims to provide a faster path to revenue amidst the company's financial struggles. Despite the potential benefits, traders are concerned about the implications for Profusa's already weak balance sheet. The deal remains tentative, contingent on final terms and funding arrangements.
Don't miss Profusa's next move
Get an email the moment Profusa makes an acquisition, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Privately held diagnostics and toxicology testing company?
Privately held diagnostics and toxicology testing company was acquired by Profusa, based in California. The deal was reported on August 18, 2026. Profusa, Inc. is a corporation based in California that specializes in healthcare-related technologies. The company is involved in innovative solutions that address critical healthcare needs. Profusa is publicly traded (PFSA) and operates in Health Care.
When did Profusa acquire Privately held diagnostics and toxicology testing company?
Profusa's acquisition of Privately held diagnostics and toxicology testing company was reported on August 18, 2026. Profusa Inc. announced a non-binding term sheet to acquire a privately held diagnostics and toxicology testing company. This acquisition aims to provide a faster path to revenue amidst the company's financial struggles. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Privately held diagnostics and toxicology testing company do?
The acquiree is a commercial-stage company specializing in diagnostics and toxicology testing. It is strategically positioned to provide services that could enhance the acquirer's revenue stream. It is privately held, operating in Biotechnology.